S&S Healthcare Holding Ltd

S&S Healthcare Holding Ltd has a liquidity position that is relatively strong, with a current ratio of 2.93, indicating that the company has nearly three times more current assets than current liabilities. However, the company's operating cash flow is negative at -26,657,000 TWD, and free cash flow is also negative at -31,913,000 TWD, suggesting that the company is not generating sufficient cash from operations to fund its activities. Profitability metrics for S&S Healthcare Holding Ltd are concerning, with a return on equity of -20.88% and a return on assets of -12.54%. These figures are below the industry median for the Advanced Medical Equipment & Technology industry, indicating that the company is underperforming in terms of generating returns for shareholders and utilizing its assets efficiently. The company's revenue is primarily concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification reported. This concentration could pose a risk if the segment experiences a downturn or if there are regulatory or market changes affecting the segment. The company's growth trajectory is mixed, with the most recent actual revenue reported at 463,700,000 TWD. However, the company's operating income and net income are both negative, indicating a decline in profitability. The company's capital expenditures are relatively low at -3,522,000 TWD, suggesting a conservative approach to investment. Risk factors for S&S Healthcare Holding Ltd include a low liquidity risk and a low dilution risk, as no immediate filing-based liquidity or dilution flags were detected. The company's debt-to-equity ratio is 0.13, indicating a low level of leverage. However, the negative operating and net income suggest that the company may need to seek additional financing in the future, which could lead to increased debt or equity dilution. Recent events for S&S Healthcare Holding Ltd include the most recent actual revenue report of 463,700,000 TWD. There are no recent filings or transcripts indicating significant changes in the company's operations or financial position.